A lawyer who represents Children's Health Defense—the rabid anti-vaccine organization founded by the equally fervent anti-vaccine advocate and current US health secretary, Robert F. Kennedy Jr.—has filed a lawsuit against Kennedy, alleging that he has failed to set up a task force to promote safer childhood vaccinations.

The task force's creation is outlined in the National Childhood Vaccine Injury Act of 1986, which is mainly known for setting up the National Vaccine Injury Compensation Program. The program provides compensation to people who have credible claims that they were injured by a vaccination, such as experiencing a very rare, severe side effect. It acts as a no-fault alternative to costly lawsuits against pharmaceutical companies. Otherwise, those lawsuits could deter pharmaceutical companies from marketing and developing vaccines, which would create a grave threat to vaccination rates and public health.

Tucked into the 1986 law is also a provision that states the US health secretary "shall establish a task force on safer childhood vaccines." The task force is intended to "promote the development of childhood vaccines that result in fewer and less serious adverse reactions than those vaccines on the market on the effective date of this part and promote the refinement of such vaccines." The task force is supposed to provide progress reports to Congress, which are to be submitted every two years.

Read full article

Comments

This story was originally published by ProPublica.

Five months after taking over the federal agency responsible for the health of all Americans, Robert F. Kennedy Jr. wants to overhaul an obscure but vital program that underpins the nation’s childhood immunization system.

Depending on what he does, the results could be catastrophic.

Read full article

Comments

Nearly 800,000 doses of mpox vaccine pledged to African countries working to stamp out devastating outbreaks are headed for the waste bin because they weren't shipped in time, according to reporting by Politico.

The nearly 800,000 doses were part of a donation promised under the Biden administration, which was meant to deliver more than 1 million doses. Overall, the US, the European Union, and Japan pledged to collectively provide 5 million doses to nearly a dozen African countries. The US has only sent 91,000 doses so far, and only 220,000 currently still have enough shelf life to make it. The rest are expiring within six months, making them ineligible for shipping.

"For a vaccine to be shipped to a country, we need a minimum of six months before expiration to ensure that the vaccine can arrive in good condition and also allow the country to implement the vaccination," Yap Boum, an Africa CDC deputy incident manager, told Politico.

Read full article

Comments

All 17 experts ousted from the federal vaccine advisory committee have spoken out about the drastic changes that anti-vaccine advocate and current US health secretary Robert F. Kennedy Jr. has made since taking office. Those changes include unilaterally restricting access to COVID-19 vaccines and summarily firing the entire Advisory Committee on Immunization Practices (ACIP), which had guided federal vaccine policies for more than 60 years.

"We are deeply concerned that these destabilizing decisions, made without clear rationale, may roll back the achievements of US immunization policy, impact people’s access to lifesaving vaccines, and ultimately put US families at risk of dangerous and preventable illnesses," the fired experts write in an editorial published in JAMA.

Kennedy dismissed the entire committee on June 9, accusing the former members of lacking public trust and being "plagued with persistent conflicts of interest," despite the committee's transparent disclosure and conflict of interest policies.

Read full article

Comments

On May 23, President Trump issued an executive order entitled "Restoring Gold Standard Science." And, in news that may surprise our readers, it sounds remarkably good, focusing on issues like reproducibility and conflicts of interest. While there were a few things that could be phrased better, when it comes to basic scientific practices, the language was remarkably reasonable.

So, why didn't we report on what appeared to be a rare bit of good news? I'd considered doing so, but the situation is complicated by the fact that the order is structured in a way that makes it very sensitive to who's responsible for implementing it, a situation that's subtle enough that I couldn't figure out how to handle it well. Fortunately, I only had to wait a week for a member of the Trump administration to show just how dangerous it could be and highlight its biggest problem.

On Sunday, Food and Drug Administration Commissioner Marty Makary appeared on one of the weekend news programs, where he was asked about the decision to limit pregnant people's access to the COVID-19 vaccines. The host mentioned that aggregation of studies involving a total of over 1.8 million women had shown the vaccine was safe and effective.

Read full article

Comments

Under President Trump, the Food and Drug Administration may no longer approve seasonal COVID-19 vaccines updated for the virus variants circulating that year, according to recent statements by Trump administration officials.

Since the acute phase of the pandemic, vaccine manufacturers have been subtly updating COVID-19 shots annually to precisely target the molecular signatures of the newest virus variants, which continually evolve to evade our immune responses. So far, the FDA has treated these tweaked vaccines the same way it treats seasonal flu shots, which have long been updated annually to match currently circulating strains of flu viruses.

The FDA does not consider seasonal flu shots brand-new vaccines. Rather, they're just slightly altered versions of the approved vaccines. As such, the regulator does not require companies to conduct lengthy, expensive vaccine trials to prove that each slightly changed version is safe and effective. If they did, generating annual vaccines would be virtually impossible. Each year, from late February to early March, the FDA, the Centers for Disease Control and Prevention, and the World Health Organization direct flu shot makers on what tweaks they should make to shots for the upcoming flu season. That gives manufacturers just enough time to develop tweaks and start manufacturing massive supplies of doses in time for the start of the flu season.

Read full article

Comments

A study released on Wednesday finds that a live-virus vaccine that limits shingles symptoms was associated with a drop in the risk for dementia when it was introduced. The work took advantage of the fact that the National Health Service Wales made the vaccine available with a very specific age limit, essentially creating two populations, vaccinated and unvaccinated, separated by a single date. And these populations showed a sharp divide in how often they were diagnosed with dementia, despite having little in the way of other differences in health issues or treatments.

What a day

This study didn't come out of nowhere. There have been a number of hints recently that members of the herpesvirus family that can infect nerve cells are associated with dementia. That group includes Varicella zoster, the virus that causes both chicken pox and—potentially many years after— shingles, an extremely painful rash. And over the past couple of years, observational studies have suggested that the vaccine against shingles may have a protective effect.

But it's extremely difficult to do a clinical trial given that the onset of dementia may happen decades after most people first receive the shingles vaccine. That's why the use of NHS Wales data was critical. When the first attenuated virus vaccine for shingles became available, it was offered to a subset of the Welsh population. Those who were born on or after September 2, 1933, were eligible to receive the vaccine. Anyone older than that was permanently ineligible.

Read full article

Comments